Delivery Order SPE2DB24D3013-SPE2DB25FFGDC

Award Date 10/31/24
Potential Completion Date 11/22/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $10,257.48 for the delivery of 4,567,079,548 units of Botox 200-unit vials. The contract is a Firm Fixed Price Delivery Order with a performance period extending to February 19, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
This federal contract award, valued at $13,971.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200-unit vials of the prescription drug Botox. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Firm Fixed Price Delivery Order contract valued at $21,369.75 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 200-unit vials of Botox, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Botox 200 unit vials. The contract is a Delivery Order with a Firm Fixed Price of $36,092.06 and a completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $89,752.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,005,584 units of Botox 200 unit vials, with a completion date of February 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,746.39 firm fixed-price delivery order is for the procurement of 200-unit vials of Botox, a specialty medication used for various medical treatments. The contract has a completion date of July 25, 2024 and was awarded on July 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Botox 200 unit vials to support military and veteran healthcare programs. The $3,492.78 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under its $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,221.40, is a Firm Fixed Price delivery order for the procurement of 4,566,953,248 units of BOTOX 100 unit vials. The ultimate completion date for this award is February 6, 2025. Amerisourcebergen maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $6,985.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of June 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order contract valued at $6,985.56 with the Defense Logistics Agency (DLA) for the delivery of 200-unit vials of Botox. The contract has an ultimate completion date of August 27, 2024 and was awarded on August 6, 2024. The contract is a Firm Fixed Price agreement and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFGDC
    Delivery Order

The federal contract award in question was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,328.52, is for the delivery of 200-unit vials of Botox. It is a Firm Fixed Price Delivery Order contract with a completion date of November 22, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical and medical supply distributor, Amerisourcebergen plays a critical role in supplying essential medical products to various federal government agencies, particularly within military and veterans' healthcare systems.

Generated 1/30/25, 9:22 AM